Table 1.
Disease | Manifestation | Diagnostic Approach | Additional Considerations |
---|---|---|---|
Lyme disease | Erythema migrans | Visual inspection of skin lesion9 | Serology not recommended because seropositivity <40% on acute phase serum sample8. |
Extracutaneous manifestations including but not limited to: facial nerve palsy, meningitis, radiculopathy, myopericarditis, arthritis | Serologic testing132: EIA followed by western blot (IgM and IgG western blots if ≤4 weeks of symptoms; IgG western blot only if >4 weeks or for Lyme arthritis)a | In Lyme meningitis, consider testing CSF for intrathecal borrelial antibody production and for borrelial DNA5; in Lyme arthritis, consider testing synovial fluid for borrelial DNA43. | |
HGA | Fever, typically with leukopenia, thrombocytopenia, and/or increased transaminases | Blood smear87; buffy coat smear; PCR for A. phagocytophilum DNA. |
Serology not routinely recommended except for retrospective diagnosis in treated patients. Seropositivity < 50% on acute phase serum sample and seropositivity alone does not establish the presence of active infection55. Failure to defervesce within 48 hours of initiation of doxycycline is evidence against the diagnosis2. |
Babesiosis | Fever, typically with anemia, thrombocytopenia, elevated lactate dehydrogenase, hyperbilirubinemia and/or increased transaminases | Blood smear preferred56; PCR for B. microti DNA is an alternative. |
Serologic testing for IgM/IgG antibodies by indirect immunofluorescent assay can be performed, but seropositivity per se does not indicate active infection56. |
see text for potential alternative testing strategies under consideration